Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.

Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...

AM, all 20 Nifty Pharma constituents traded in the green. Among others, Gland Pharma was up 7.74 per cent, Lupin was up over ...

Pharma stocks surge after US exempts products from tariffs, Nifty Pharma and healthcare indices show positive gains.

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With ...

It’s a party for pharma stocks on Dalal Street. The Nifty Plarma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...

Indian pharmaceutical industry welcomes U.S. tariff exemption, boosting stock prices and reinforcing commitment to affordable, quality medicines.

While the Nifty IT index lost 4.21 per cent due to US recession fears, investors found comfort in the pharma sector, which ...

Indian equities brace for a roller coaster session on Thursday, April 3, as US President Donald Trump, in the early hours of ...

Currently, US charges nearly zero duty on pharmaceutical imports, while India imposes around 10 percent tax on pharma imports ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...